📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 333 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
333
இன்று
169,034
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,996
நேர்மறை
8,544
எதிர்மறை
100,683
நடுநிலை
9,743
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
1,000+ அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: LT
நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Q2 FY27 Adjusted PAT Jumps 249% YoY to ₹56 Cr; Revenue Up 31% to ₹446 Cr

GHCL Textiles reported strong standalone results for Q2 FY27, with total revenue rising 31% YoY to ₹446 crore and EBITDA surging 141% YoY to ₹92 crore. Adjusted net profit increased 249% YoY to ₹56 crore, after adjusting for an exceptional loss of ₹27 crore (₹20 crore net of tax) due to a fire at its Tuticorin godown. For H1 FY27, revenue reached ₹856 crore (up 40% YoY) and adjusted PAT stood at ₹95 crore (up 223% YoY). The company's fabric revenue share expanded to 16.4% from 11.4% in Q2 FY26, supporting higher margin realization.

எதிர்மறை தாக்கம் 5/10 நிதி முடிவுகள்

Orient Press Q2 FY27 Net Loss at ₹0.64 Cr vs ₹0.76 Cr YoY; Revenue Drops 20% to ₹30.03 Cr

Orient Press reported Q2 results for the quarter ended September 30, 2026, with revenue from operations declining 20.1% YoY to ₹30.03 Cr compared to ₹37.61 Cr in Q2 FY26. Net loss narrowed slightly to ₹0.64 Cr (₹63.60 Lakhs) from a loss of ₹0.76 Cr (₹75.55 Lakhs) in the corresponding quarter last year. For H1 FY27, revenue stood at ₹51.56 Cr with a total comprehensive loss of ₹1.85 Cr. The company continues to face profitability pressure amid elevated finance costs of ₹1.58 Cr in Q2.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2 FY27 PAT Jumps 45.2% YoY to ₹15.4 Cr; Total Income at ₹138.6 Cr

GPT Healthcare reported strong growth for Q2 FY27, with Total Income increasing 15.2% YoY to ₹138.6 crore and Profit After Tax surging 45.2% YoY to ₹15.4 crore. Operating EBITDA expanded 23.9% YoY to ₹29.8 crore, driven by a 150 bps margin improvement to 21.5%. For H1 FY27, net profit stood at ₹28.1 crore, already exceeding the entire TTM PAT of ₹17 crore. Operational performance gained momentum as network occupancy rose to 50.3% in Q2, with ARPOB increasing 7.1% YoY to ₹40,721.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Oriental Trimex Reports Q2 FY27 Results; H1 PBT at Rs 162.61 Lakhs

Oriental Trimex Limited approved its un-audited standalone financial results for the quarter and half-year ended September 30, 2026. For the half-year period (H1 FY27), the company reported a net profit before tax of Rs 162.61 lakhs compared to Rs 278.24 lakhs in the full preceding year FY26. Operating cash flow before working capital adjustments stood at Rs 116.20 lakhs for H1, while closing cash and cash equivalents were Rs 58.91 lakhs. The Limited Review Report by statutory auditors was unmodified with no adverse qualifications.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

India Shelter Reports Q2FY27 PAT of ₹146 Cr, Up 21% YoY; Gross AUM Reaches ₹11,997 Cr

India Shelter Finance Corporation reported its Q2FY27 results in its investor presentation, with PAT rising 21% YoY to ₹146 Cr. Gross AUM expanded 19% YoY to reach ₹11,997 Cr, supported by quarterly disbursements of ₹1,126 Cr (up 23% YoY). Asset quality remained stable with Gross Stage 3 at 1.2% and Net Stage 3 at 0.6%, accompanied by a provision coverage ratio of 52%. Return metrics stood healthy with ROA at 5.7% and ROE at 17.3%, supported by net worth of ₹3,401 Cr.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நடுநிலை தாக்கம் 5/10 டிவிடெண்ட்

GPT Healthcare Declares ₹1.00 Interim Dividend for FY 2026-27; Record Date Nov 12, 2026

GPT Healthcare Limited has declared an interim dividend of ₹1.00 per equity share (10% of face value of ₹10) for FY 2026-27. At the current share price of ₹144.2, this represents an interim dividend yield of approximately 0.69%. The payout amounts to roughly ₹8.2 crore on its ~8.2 crore share base, representing about 48% of its TTM net profit of ₹17 crore. The record date to determine shareholder eligibility is November 12, 2026, with payout scheduled on or before December 4, 2026.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2 FY27 PAT Rises 20.4% YoY to ₹145.63 Cr; Total Income at ₹450.45 Cr

India Shelter Finance reported a 20.4% YoY increase in standalone net profit to ₹145.63 crore for the quarter ended September 30, 2026, compared to ₹120.93 crore in Q2 FY26. Total income grew 22.1% YoY to ₹450.45 crore, supported by interest income expanding to ₹369.33 crore. Finance costs rose to ₹128.34 crore, while impairment on financial instruments jumped 71.2% YoY to ₹16.31 crore. For H1 FY27, net profit stood at ₹287.64 crore on total income of ₹883.50 crore.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

VTM Limited Reports Q2 Results with Unmodified Auditor Opinion for Quarter Ended Sep 30, 2026

VTM Limited has submitted its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported that the statutory auditors, M/s. CNGSN & Associates LLP, issued an unmodified limited review report. The board meeting commenced at 10:45 AM and concluded at 02:35 PM on November 5, 2026. Detailed financial numbers in the filing extract are partially truncated, but standard quarterly disclosure obligations have been completed.

நேர்மறை தாக்கம் 6/10 டிவிடெண்ட்

Emami Declares ₹5/Share Interim Dividend (500%), Approves Q2 Results & Appoints CS

Emami Limited's Board approved its Q2 FY27 financial results and declared a 1st Interim Dividend of ₹5 per equity share (500% on face value of ₹1) on 42.92 crore equity shares, amounting to an outflow of ~₹214.6 crore. The record date is set for November 13, 2026, with payment on or before December 4, 2026. The company also announced the appointment of Shri Debendra Banthiya as Company Secretary and Compliance Officer effective November 5, 2026. Additionally, the filing noted the successful completion of a ₹281.24 crore share buyback in October 2026 and highlighted auditors' qualified conclusion regarding unreviewed results of certain subsidiaries representing ₹83.57 crore in revenue.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Emami Q2FY27 Revenue Up 36% to ₹1,088 Cr; Declares ₹5 Dividend

Emami reported consolidated revenue from operations of ₹1,088 crore for Q2FY27, up 36% YoY (24% like-to-like), supported by a 49% growth in its domestic business. Operating EBITDA increased 25% YoY to ₹222 crore, though Profit After Tax declined 2.7% to ₹144.4 crore due to higher effective tax rates following the phase-out of fiscal benefits. The Board declared a first interim dividend of ₹5 per share (500% payout totaling ₹214.6 crore) and completed an open-market share buyback worth ₹281.24 crore. Capital returned to shareholders via buyback and interim dividend amounts to ₹495.8 crore, representing ~2.9% of its ₹16,875 crore market capitalization.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

GHCL Textiles Q2 FY27 Net Profit Rises 124% YoY to ₹35.84 Cr, Revenue Up 31.8%

GHCL Textiles reported a strong operational performance for Q2 FY27 (ended September 30, 2026), with revenue from operations growing 31.8% YoY to ₹445.53 crore compared to ₹338.04 crore in Q2 FY26. Net profit surged 123.9% YoY to ₹35.84 crore despite an exceptional loss of ₹26.78 crore booked during the quarter. Profit before exceptional items and tax jumped 243% YoY to ₹74.48 crore from ₹21.72 crore, showing significant operating margin expansion. For H1 FY27, net profit stood at ₹75.19 crore on revenue of ₹854.47 crore.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Q2 PAT Jumps 124% YoY to ₹35.84 Cr; Approves ₹415.25 Cr Spinning Capex

GHCL Textiles reported Q2 FY27 revenue from operations of ₹445.53 crore, growing 31.8% YoY from ₹338.04 crore. Net profit rose 123.9% YoY to ₹35.84 crore despite an exceptional loss of ₹26.78 crore caused by a fire incident at its Tuticorin godown (insurance claim pending). Alongside results, the Board approved an additional FY27 capital budget of approx. ₹415.25 crore to set up a new spinning unit with 58,368 spindles at Manaparai, Tamil Nadu, representing ~27.6% of net worth (₹1,502 crore). Additionally, the company paid ₹31.05 crore towards 56.12 acres allotted under the PM MITRA scheme at Virudhunagar.

கண்காணிப்பு தாக்கம் 6/10 நிதி முடிவுகள்

Indiabulls Ltd Q2 FY27 Results Approved; Terminates Sept 11 Definitive Agreement

Indiabulls Limited approved its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company announced that parties to its Definitive Agreement dated September 11, 2026, mutually agreed to terminate all rights and obligations without any inter-se claims or liabilities. In the standalone cash flow for H1 FY27, net cash from operations turned positive to ₹107.70 crore compared to a cash outflow of ₹120.57 crore in H1 FY26. Total standalone equity increased to ₹6,709.02 crore as of September 30, 2026, from ₹6,346.84 crore as of March 31, 2026.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2 PAT Doubles to ₹151.1 Cr (+101% YoY); Real Estate Pipeline Expands to ₹27,308 Cr

Indiabulls Limited reported strong Q2FY27 financial performance with revenue from operations rising 31% YoY to ₹336.4 crore and PAT jumping 101% YoY to ₹151.1 crore. For H1FY27, revenue reached ₹720.8 crore (+100% YoY) and PAT surged 297% YoY to ₹292.1 crore. In its real estate business, the company added a Dwarka Expressway project with a Gross Development Value (GDV) of ₹3,700 crore, bringing total portfolio GDV to ₹27,308 crore. Additionally, the company received ₹250 crore of its ₹1,000.07 crore preferential equity raise and terminated its proposed acquisition of Fintech Cloud Private Limited.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Pricol Q2 FY27 Net Profit Rises 33% YoY to ₹85.21 Cr; Revenue Up 35% to ₹1,334 Cr

Pricol released its Q2 FY27 investor presentation showing a strong consolidated operational performance. Revenue from operations increased 35.0% YoY to ₹1,334.02 Cr compared to ₹987.93 Cr in Q2 FY26. Consolidated EBITDA rose 27.9% YoY to ₹157.73 Cr with margins at 11.82%, while Profit After Tax (PAT) grew 33.2% YoY to ₹85.21 Cr (EPS ₹6.99). For H1 FY27, revenue reached ₹2,417.60 Cr with a PAT of ₹152.23 Cr, supported by new product launches including 5-inch TFT clusters for Bajaj Pulsar models.

நேர்மறை தாக்கம் 8/10 விரிவாக்கம்

Ravindra Energy Reports Q2 Revenue of ₹190.3 Cr (+80% YoY), Advances EIM Merger & EV Plant

Ravindra Energy released its Q2 FY27 business update highlighting consolidated turnover of ₹190.33 Cr (₹1,903.3 Mn), up 80.4% YoY from ₹105.53 Cr in Q2 FY26. Consolidated EBITDA reached ₹53.1 Cr with PAT at ₹19.04 Cr. Total operating renewable capacity stood at 296 MWp, alongside 226.8 MWp under construction to reach 522.8 MWp. In parallel, merger steps with EIM (Energy In Motion) are underway with an EV heavy-truck assembly plant inaugurated in Pune featuring an annual capacity of 5,000 trucks/shift and a 2.4 GWh battery-pack line.

எதிர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

All Time Plastics Q2 FY27 Investor Presentation: Revenue Up 18% to ₹174 Cr, EBITDA Drops 16%

All Time Plastics reported Q2 FY27 standalone revenue of ₹174.0 crore, up 18.0% YoY, but EBITDA fell 15.8% YoY to ₹13.7 crore as margins contracted from 11.0% to 7.9%. Margin compression was driven by a 40–45% surge in key polymer prices due to West Asia conflicts, combined with fixed export pricing and shipping bottlenecks. Net profit stood flat at ₹4.2 crore (2.4% PAT margin). Management expects its Guwahati bamboo facility to start commercial production in mid-November 2026, targeting ₹25–30 crore revenue in CY2027.

நேர்மறை தாக்கம் 5/10 ஒழுங்குமுறை

Alembic Pharma Gets USFDA Approval for Olopatadine Solution (US$20M Market)

Alembic Pharmaceuticals has received final USFDA approval for its ANDA Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), co-developed with Orbicular Pharmaceutical Technologies. The reference drug, Pataday Once Daily Relief, addresses itchy eyes and had an estimated US market size of US$20 million for the 12 months ending September 2026. This approval brings Alembic's cumulative tally to 248 ANDA approvals (229 final and 19 tentative). While positive for its ophthalmic portfolio, the product's total addressable market is modest relative to Alembic's TTM revenue of Rs 7,784 crore.

கண்காணிப்பு தாக்கம் 9/10 சட்டம்

DPSCLTD: CoC Approves Extension of CIRP and Resolution Plan Submission Timelines

DPSC Limited (formerly India Power Corporation Limited), which was admitted into the Corporate Insolvency Resolution Process (CIRP) via NCLT Hyderabad order dated May 15, 2026, reported the voting results of its 9th Committee of Creditors (CoC) meeting. The CoC has approved an extension of the CIRP timeline and the deadline for the submission of resolution plans. The e-voting on these resolutions concluded on November 3, 2026, at 6:15 p.m. This process directly governs the ownership and debt restructuring of the company, which holds ₹119 Cr in debt against a market cap of ₹622 Cr.

நடுநிலை தாக்கம் 5/10 BOARD_MEETING

All Time Plastics Approves ₹5 Cr Investment in Bamboo Subsidiary & Q2 FY27 Results

All Time Plastics reported its board meeting outcome for the quarter and half-year ended September 30, 2026, approving unaudited standalone and consolidated financial results. The board approved an additional equity investment of ₹5.00 crore in its wholly-owned subsidiary, All Time Bamboo Private Limited. Additionally, Rahul Vohra, General Manager and Senior Management Personnel, was transferred from the holding company to the bamboo subsidiary effective November 1, 2026. The company also reported utilizing ₹202.90 crore of its ₹280.00 crore total planned IPO proceeds as of September 30, 2026.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்